PCN Insights, News, Videos, and More

While treatments that improve attention-deficit/hyperactivity disorder (ADHD) in children and adolescents are diverse and growing, medications have the strongest evidence base for improved outcomes.

Sandhya Prashad, MD, discusses ketamine applications for treatment-resistant depression.

In Part 2 of this interview Lenard A. Adler, MD, explains the root causes behind the stimulant medication shortage as well as non-pharmacological strategies clinicians can share with their Adult ADHD patients.

A rapid procedural (RP) approach to withdrawal management and initiation of injectable extended-release (XR)-naltrexone for opioid use disorder (OUD) helped more patients begin treatment but may be difficult to implement widely due to...

In patients with an inadequate response to a second-generation antipsychotic, adding evenamide improved symptoms, the drug’s developer Newron Pharmaceuticals recently announced.

Dr Craig Chepke discusses his aspirations in his new role, shares insights from his career journey, and reflects on the impact of Psych Congress events on his clinical practice.

The severity of obstructive sleep apnea (OSA) events during REM sleep is associated with worse verbal memory impairment in older adults at risk for Alzheimer disease (AD), according to a study published online in the journal Alzheimer’s...